WASHINGTON: President Donald Trump’s triumphant assertions about the success of the Singapore summit are being met with skepticism and outright derision from some critics.
They’re seizing on the contradiction between Trump’s withdrawal from the Iran nuclear deal and his willingness to accept vague pledges from North Korea’s Kim Jong Un.
White House officials stress that this week’s meeting in Singapore is the beginning of a process and not its end.
The Singapore summit sets out broad goals to be met in the coming months. In contrast, the Iran deal, signed by President Barack Obama in 2015 and approved by seven nations, followed 18 months of talks.
The chairman of the Senate Foreign Affairs Committee, Tennessee Republican Bob Corker, says it’s difficult to determine what of a concrete nature has taken place.
![]()
Iran deal comparisons cloud Trump’s North Korea summit
Iran deal comparisons cloud Trump’s North Korea summit
- White House officials stress that this week’s meeting in Singapore is the beginning of a process and not its end
- The chairman of the Senate Foreign Affairs Committee, Tennessee Republican Bob Corker, says it’s difficult to determine what of a concrete nature has taken place
UK, allies convinced Kremlin critic Navalny was poisoned
- That was the conclusion of the five governments based on analyzes of samples from Alexei Navalny – statement
LONDON: Britain and allies France, Germany, Sweden and the Netherlands are convinced that late Kremlin critic Alexei Navalny was poisoned with a lethal toxin in a penal colony two years ago, they said in a joint statement on Saturday.
That was the conclusion of the five governments based on analyzes of samples from Navalny, according to the statement issued in London.
It added that the analyzes had conclusively confirmed the presence of epibatidine, a toxin found in poison dart frogs in South America and not found naturally in Russia. The Russian government has denied any responsibility for Navalny’s death.
Latest updates
Recommended
© 2026 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.